However, SASH1 expression differences were statistically significant for survival status (P = 0.025), gender (P = 0.038), and clinical stage (P = 0.01), suggesting associations with prognosis, gender differences, and tumor progression. This evidence concerns the gene SASH1 and neoplasm.